APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 143 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,349,857 | +30.9% | 61,258 | +104.2% | 0.00% | 0.0% |
Q4 2023 | $1,795,800 | -74.0% | 30,000 | -70.3% | 0.00% | -88.6% |
Q3 2022 | $6,904,000 | +203.1% | 101,085 | +100.6% | 0.04% | +169.2% |
Q2 2022 | $2,278,000 | +132.2% | 50,380 | +161.1% | 0.01% | +225.0% |
Q1 2022 | $981,000 | +190.2% | 19,298 | +261.1% | 0.00% | +300.0% |
Q2 2021 | $338,000 | -57.6% | 5,344 | -79.8% | 0.00% | -90.9% |
Q3 2020 | $797,000 | +7.1% | 26,422 | +15.9% | 0.01% | -8.3% |
Q2 2020 | $744,000 | +177.6% | 22,790 | +128.1% | 0.01% | +71.4% |
Q1 2020 | $268,000 | -57.0% | 9,991 | -50.9% | 0.01% | +75.0% |
Q4 2019 | $623,000 | -41.1% | 20,359 | -53.6% | 0.00% | -55.6% |
Q3 2019 | $1,057,000 | -34.8% | 43,897 | -31.4% | 0.01% | -43.8% |
Q2 2019 | $1,622,000 | +80.4% | 64,000 | +38.8% | 0.02% | +60.0% |
Q1 2019 | $899,000 | +58.8% | 46,111 | +7.5% | 0.01% | +42.9% |
Q4 2018 | $566,000 | +50.9% | 42,904 | +103.3% | 0.01% | +75.0% |
Q3 2018 | $375,000 | – | 21,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |